Cancer Screening and Cancer Mortality in Nevis, West Indies

Felix, A. S.; Avery, G.; Mutetwa, B.; Ishmael, R.; Ragin, C.; Taioli, E.
September 2009
West Indian Medical Journal;Sep2009, Vol. 58 Issue 4, p311
Academic Journal
Objective: Cancer screening is one approach that can reduce morbidity and mortality through early detection of pre-cancers; however anxiety, fear, and lack of information are important barriers to universal cancer screening in the Caribbean. Nevis is a small island located in the Eastern Caribbean. We report available data on screening prevalence and cancer mortality for four common cancers: cervical, breast, colon and prostate. Methods: Demographic information, screening utilization (when available) and cancer mortality statistics were obtained from the Charlestown Health Clinic and the annual reports from the Ministry of Health. Moreover, physicians and key stakeholders were interviewed to assess current guidelines for cancer screening as well as to indicate areas of need. Results: Cervical cancer screening is under-utilized in Nevis. Between 2001 and 2007, the overall prevalence of Pap testing fluctuated minutely (mean: 6.87%, range: 6.06 - 7.41%). Systematic screening for breast, colon, and prostate cancer is not routinely performed, thus utilization rates are not available. Cancer mortality varied slightly between 2002 and 2006; prostate cancer had the highest overall crude mortality rate (30.6 deaths/100 000 persons). Physician interviews revealed that adherence to US and European cancer screening guidelines are inappropriate for their population of patients. Breast and prostate cancers are frequently diagnosed in these geographic areas before the age when cancer screening is currently recommended. Conclusion: Cancer is perceived as an important health problem by physicians, key stakeholders and citizens, however cancer screening is under-utilized in Nevis. Future research should focus on generating screening guidelines that are relevant for this population, as well as methods to promote screening.


Related Articles

  • Alternative screening methods may reduce mortality in prostate cancer.  // Hem/Onc Today;4/25/2013, Vol. 14 Issue 8, p11 

    The article discusses the results of a study which showed that mortality was reduced by prostate cancer screening methods that increase the threshold for biopsy referral for older men and lessen screening among those with low prostate-specific antigen (PSA).

  • Le d�pistage de masse : partout et pour toutes ? Gairard, B.; Haehnel, P. // Oncologie;mar2004, Vol. 6 Issue 2, p79 

    The results from pilot experiments and breast cancer screening programmes have shown that it was possible to obtain a similar efficiency using a procedure adapted to our health system. The objective of the new protocol is to have an increasing homogeneity in medical breast care practice,...

  • A screening programme that worked: discussion paper. Hakama, M. // Journal of the Royal Society of Medicine;May1990, Vol. 83 Issue 5, p322 

    The article focuses on a screening program designed to identify cervical cancer and to reduce the risk of death caused by cervical cancer in five Nordic countries. The program was proved beneficial as it was applied in a well organized manner on a wide target age range. The screening program...

  • Early Diagnosis of Cancer by Detecting the Chemiluminescence of Hematoporphyrins in Peripheral Blood Lymphocytes. KOHNO, MASAHIRO; TAKEDA, MOTOHIRO; NIWANO, YOSHIMI; SAITO, RUMIKO; EMOTO, NATSUMI; TADA, MIKA; KANAZAWA, TAKEMICHI; OHUCHI, NORIAKI; YAMADA, RIE // Tohoku Journal of Experimental Medicine;Oct2008, Vol. 216 Issue 2, p47 

    Early detection and optimal treatment are the most effective means to improve cancer mortality. Mass screening for cancer has yielded a marked reduction of cancer mortality in the United States. Simple and effective methods are expected for screening of malignancy. Hematoporphyrin derivatives...

  • Bowel screening scheme detecting cancer earlier.  // Pulse;11/11/2009, Vol. 69 Issue 36, p14 

    The article reports on the study on the effectiveness of the National Bowel Cancer Screening program in Wolverhampton, England. It is stated that the research found that 45 percent of screened colorectal cancer patients are in the earliest stage or stage A, while 22 percent are in stage B. It...

  • DAKOTA CARE Update: Healthcare Quality Part 3: Cancer Screenings. Amundson, E. Paul // South Dakota Medicine;Aug2015, Vol. 68 Issue 8, p370 

    The article looks at cancer screening rates in the U.S. in August 2015. Topics discussed include a U.S. Centers for Disease Control and Prevention (CDC) report which revealed a decrease in the overall cancer mortality rates for adults in the country, factors attributed to the decrease, and...

  • Recognising the benefits and harms of breast cancer screening: an opportunity to target improvement. O'Donoghue, C; Esserman, L // British Journal of Cancer;6/11/2013, Vol. 108 Issue 11, p2200 

    The authors comment on the report "The Independent UK Panel on Breast Cancer Screening: The Benefits and Harms of Breast Cancer Screening: An Independent Review," by G. Marmot and colleagues published in the 2013 issue. They agree that the panel outlines in the report the opportunities to reduce...

  • Should we screen for breast cancer? McPherson, Klim // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/31/2010, Vol. 341 Issue 7766, p233 

    In this article, the author explores evidence on the benefits and harms of screening for breast cancer. The author argues that detecting tumors before they become clinically apparent is a good idea. She adds that screening for a progressive disease can be justified if earlier diagnosis and...

  • The high cost of cost containment. Carson, Culley C. // Contemporary Urology;Sep2004, Vol. 16 Issue 9, p11 

    Deals with issues concerning the use of prostate-specific antigen (PSA) test as part of prostate cancer screening. Impact of the introduction of PSA resting on prostate cancer mortality; Uncertainties about the benefits of PSA testing compared to risks; Difference between the use of prostate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics